Anavex Life Sciences Corp. (AVXL) Live Share Price, Invest From India

Anavex Life Sciences Corp. Stock Performance

as on March 28, 2026 at 6:59 am IST

Day's Low
Day's High
$2.75
Day's Price Range
$2.89
$2.81
2.14%
Downside
2.85%
Upside
52 Week's Low
52 Week's High
$2.61
52-Week Price Range
$13.99
$2.81
7.12%
Downside
397.86%
Upside

Anavex Life Sciences Corp. share price movements today

Previous Close: $2.88
Open: $2.86
Volume: 2.7M
Day's Low - High: $2.75 - $2.89
52 Week Low - High: $2.61 - $13.99

Anavex Life Sciences Corp. Historical Returns

1 Month Return: -36.34 %
3 Month Return: -22.53 %
1 Year Return: -67.66 %
3 Year Return: -66.11 %
5 Year Return: -81.15 %

Anavex Life Sciences Corp. Stock Fundamentals & Key Indicators

Check Anavex Life Sciences Corp. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$261.3M

EPS (TTM)

-0.325

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-33.64%

Anavex Life Sciences Corp. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Anavex Life Sciences Corp. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Anavex Life Sciences Corp.	BUY	$261.3M	-81.15%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$43.5B	132.92%	140.84	8.45%
Vertex Pharmaceuticals Incorporated	BUY	$115.2B	101.77%	29.58	32.94%
Beone Medicines Ltd	NA	$31.8B	NA	112.58	5.37%
Regeneron Pharmaceuticals, Inc.	BUY	$80.0B	54.69%	18.25	31.41%

Stock Returns calculator for Anavex Life Sciences Corp. Stock including INR - Dollar returns

The Anavex Life Sciences Corp. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Anavex Life Sciences Corp. investment value today

Current value as on today

₹42,734

Returns

₹57,266

(-57.27%)

Returns from Anavex Life Sciences Corp. Stock

₹67,775 (-67.78%)

Dollar Returns*

₹10,509 (+10.51%)

Analyst Recommendation on Anavex Life Sciences Corp. Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Anavex Life Sciences Corp.. Average target price of $22

Anavex Life Sciences Corp. Share Price Target

Get share price movements and forecasts by analysts on Anavex Life Sciences Corp..

What analysts predicted

87.23%UPSIDE

Target Price

$22

Current Price

$2.81

Analyzed by

9 Analysts

Target

$22.00

Anavex Life Sciences Corp. target price $22, a slight upside of 87.23% compared to current price of $2.81. According to 9 analysts rating.

Anavex Life Sciences Corp. Stock’s Investor Sentiment and Interest

Search interest for Anavex Life Sciences Corp. Stock has increased by 34% in the last 30 days, reflecting an upward trend in search activity.

Time period: February 26, 2026 to March 28, 2026

Change:34% versus previous 30 day period

Anavex Life Sciences Corp. Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-
Operating Income	-12	-11	-12	-14	-14	-13	-12	-14	-10	-6
EBITDA	-10	-11	-12	-14	-11	-13	-12	-14	-6	-6
Interest Expense	1	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-10	-8	-10	-12	-11	-12	-11	-13	-9	-5
Income Tax Expense	0	0	0	0	0	0	0	0	-	0
Net Income	-10	-8	-10	-12	-11	-12	-11	-13	-9	-5
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Anavex Life Sciences Corp. Annual Profit & Loss

All numbers in Millions USD

	Sep 2016	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Total Revenue	-	-	-	0	-	-	-	-	-	-
Gross Profit	0	-	-	-	-	-	-	-	-	-
Operating Income	-15	-15	-19	-28	-31	-42	-50	-47	-52	-51
EBITDA	-15	-15	-19	-28	-31	-37	-47	-47	-43	-46
Interest Expense	11	-	0	0	4	4	0	0	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-14	-13	-17	-26	-26	-37	-47	-47	-43	-46
Income Tax Expense	0	0	0	0	0	0	0	0	-2	0
Net Income	-14	-13	-17	-26	-26	-37	-47	-47	-43	-46
Net Profit Margin	0.00%	0.00%	0.00%	3838.68%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Anavex Life Sciences Corp. Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-8	-10	-12	-11	-12	-11	-13	-9	-5
Operating Cash Flow	-7	-11	-5	-6	-12	-5	-12	-8	-7
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	0	7	4	0	0	0	-2	10	36
Change in Cash	-7	-4	0	-6	-11	-5	-14	1	29

Anavex Life Sciences Corp. Annual Cash Flow

All numbers in Millions USD

	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Net Income	-13	-17	-26	-26	-37	-47	-47	-43	-46
Operating Cash Flow	-9	-12	-18	-21	-30	-24	-27	-30	-39
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	27	8	17	28	153	21	29	11	9
Change in Cash	18	-4	0	7	122	-2	1	-18	-29

Global Institutional Holdings in Anavex Life Sciences Corp.

Funds	Holdings
Morgan Stanley - Brokerage Accounts	0.6%
Susquehanna International Group, LLP	0.47%
Bank of America Corp	0.48%
Geode Capital Management, LLC	2.19%
Franklin Resources Inc	0.4%

See all

Insights on Anavex Life Sciences Corp.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 18.2% return, outperforming this stock by 85.9%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 68.3% return, outperforming this stock by 134.4%
NEGATIVE IMPACT
Price Dip
In the last 7 days, AVXL stock has moved down by -30.5%

About Anavex Life Sciences Corp.

anavex life sciences corp. is a clinical stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodevelopmental and neurodegenerative diseases. anavex is currently in a phase 2a trial for alzheimer's disease (ad) with lead therapeutic, anavex 2-73, an orally available small molecule targeting protein misfolding and cellular stress through activating the sigma-1 receptor. part a topline data of our ongoing phase 2a trial demonstrate a favorable safety, bioavailability, dose-response curve and tolerability/risk profile. anavex 2-73 is a potential platform drug showing encouraging preclinical data rare neurodevelopmental disease: rett syndrome, as well is in epilepsy and multiple sclerosis (ms). in 2015, the company was awarded a research by the michael j. fox foundation (mjff) to study anavex 2-73 for the treatment of parkinson’s disease. headquartered in new york, anavex is an american publicly traded corporation quoted as avxl.

Organisation	Anavex Life Sciences Corp.
Headquarters	630 5th Avenue, New York, NY, United States, 10111
Industry	Health Technology
CEO	Dr. Christopher U. Missling M.B.A., M.S., Ph.D.
E-voting on shares	Click here to vote

Key Management of Anavex Life Sciences Corp.

Name	Title
Dr. Juan Carlos Lopez-Talavera M.D., Ph.D.	Senior VP & Head of Research and Development
Dr. Wolfgang Liedtke M.D., Ph.D.	Senior VP & Global Head of Neurology
Dr. Christopher U. Missling M.B.A., M.S., Ph.D.	President, CEO, Secretary & Director
Ms. Sandra Boenisch CPA, CGA	Principal Financial Officer & Treasurer
Clint Tomlinson	VP of Corporate
Dr. Adebayo Laniyonu Ph.D.	Senior Vice President of Nonclinical Development
Dr. Kun Jin Ph.D.	Vice President & Head of Biostatistics
Dr. Terrie Kellmeyer Ph.D.	Senior Vice President of Clinical Development

FAQs

What is Anavex Life Sciences Corp. share price today?

Anavex Life Sciences Corp. share price today is $2.81 as on March 28, 2026 at 1:29 am IST at the close of the market. Anavex Life Sciences Corp. share today touched a day high of $2.89 and a low of $2.75.

What is the 52 week high and 52 week low for Anavex Life Sciences Corp. share?

Anavex Life Sciences Corp. share touched a 52 week high of $13.99 on July 24, 2025 and a 52 week low of $2.61 on March 25, 2026. Anavex Life Sciences Corp. stock price today i.e. March 28, 2026 at 1:29 am IST is closed at $2.81,which is 79.91% down from its 52 week high and 7.66% up from its 52 week low.

What is Anavex Life Sciences Corp.'s market capitalisation today?

Anavex Life Sciences Corp. market capitalisation is $0.00T as on March 28, 2026 at 1:29 am IST.

How to invest in Anavex Life Sciences Corp. Stock (AVXL) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Anavex Life Sciences Corp. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Anavex Life Sciences Corp. Shares that will get you 0.5338 shares as per Anavex Life Sciences Corp. share price of $2.81 per share as on March 28, 2026 at 1:29 am IST.

What is the minimum amount required to buy Anavex Life Sciences Corp. Stock (AVXL) from India?

Indian investors can start investing in Anavex Life Sciences Corp. (AVXL) shares with as little as ₹94.651 or $1 (as of March 28, 2026 at 3:37 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹946.51 in Anavex Life Sciences Corp. stock (as per the Rupee-Dollar exchange rate as on March 28, 2026 at 3:37 pm IST). Based on Anavex Life Sciences Corp. share’s latest price of $2.81 as on March 28, 2026 at 1:29 am IST, you will get 3.5587 shares of Anavex Life Sciences Corp.. Learn more about fractional shares .

What are the returns that Anavex Life Sciences Corp. has given to Indian investors in the last 5 years?

Anavex Life Sciences Corp. stock has given -81.15% share price returns and 29.26% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?